Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Oral Squamous Cell Carcinoma
NCT02739204Phase 2Unknown
- Sponsor
- China Medical University Hospital
- Start
- Nov 2013
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in oral squamous cell carcinoma (OSCC), sponsored by China Medical University Hospital. Status: unknown.
02
Drugs
celecoxib
03
Conditions
oral squamous cell carcinoma (OSCC)
Beyond the preview
Go deeper on NCT02739204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02739204.